IPHA
Innate Pharma
IPHA
IPHA
9 hedge funds and large institutions have $255K invested in Innate Pharma in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
RhumbLine Advisers
Boston,
Massachusetts
|
$1.25K |
2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
$828 |
Top Sellers
1 |
Optiver Holding
Amsterdam,
Netherlands
|
$187 |
2 |
Citadel Advisors
Miami,
Florida
|
$21.9K |
3 |
UBS Group
Zurich,
Switzerland
|
$6.46K |